Equity Analysis

Profit & Loss

    Trident Lifeline Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    543616
    INE0MKA01014
    51.3768784
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    33.95
    351.01
    EPS(TTM)
    Face Value()
    Div & Yield %:
    8.99
    10
    0
     
Particulars(INCOME)Mar 2024
( Cr)
Mar 2023
( Cr)
Mar 2022
( Cr)
Mar 2021
( Cr)
Mar 2020
( Cr)
Sales Turnover 44.6531.6921.779.624.93
Excise Duty0.000.000.000.000.00
Net Sales44.6531.6921.779.624.93
Other Income 2.201.150.600.160.07
Stock Adjustments 0.672.890.460.410.09
Total Income47.5235.7322.8310.195.09
EXPENDITURE :
Raw Materials 30.2323.1214.695.923.40
Power & Fuel Cost0.070.030.020.020.02
Employee Cost 1.551.391.100.700.71
Other Manufacturing Expenses 2.542.382.661.290.38
Selling & Administrative Expenses 1.360.980.940.830.78
Miscellaneous Expenses 0.700.420.110.010.01
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.00
Total Expenditure36.4528.3319.528.785.30
Operating Profit11.087.423.321.41-0.20
Interest 0.510.480.130.410.76
Gross Profit10.576.943.191.00-0.96
Depreciation0.770.360.200.140.12
Profit Before Tax9.806.582.990.86-1.08
Tax2.380.04-0.140.000.00
Fringe Benefit tax0.000.000.000.000.00
Deferred Tax0.370.52-0.820.22-0.28
Reported Net Profit7.046.013.950.63-0.80
Extraordinary Items 0.010.000.000.000.01
Adjusted Net Profit7.036.013.950.63-0.81
Adjustment below Net Profit 0.00-0.500.00-0.632.60
P & L Balance brought forward2.29-3.22-7.17-6.10-7.11
Statutory Appropriations0.000.000.000.000.00
Appropriations 0.000.000.00-0.630.80
P & L Balance carried down9.332.29-3.22-5.47-6.10
Dividend0.000.000.000.000.00
Preference Dividend0.000.000.000.000.00
Equity Dividend %0.000.000.000.000.00
Dividend Per Share(Rs)0.000.000.000.000.00
Earnings Per Share-Unit Curr6.135.234.931.26-2.57
Earnings Per Share(Adj)-Unit Curr6.135.234.931.26-2.57
Book Value-Unit Curr45.8139.685.97-0.94-9.69
Book Value(Adj)-Unit Curr45.8139.685.97-0.94-9.69